Axendia’s Analysis of the Root Causes and Our Recommendations to Prevent Them There has been a lot of buzz around FDA’s warning letter which for […]
FDA Calls Out Inappropriate Use of Artificial Intelligence Read More »
QAD Adaptive and Champion AI Briefing Note QAD Leadership including Tom Roberts, Vice President of Strategic Industry Development and Robyn Coward, Life Sciences Director, outlined
Moving from Systems of Record to Systems of Action Read More »
Medidata NEXT NY 2026 Event Brief The life sciences industry is navigating a period of continuous disruption driven by scientific complexity, operational pressure, regulatory modernization,
AI Agents and Virtual Twins Redefine the Future of Life Sciences Read More »
Genari AI Briefing Note Axendia was briefed by Rosalind Beasley, Co-founder and CEO, and Tim Kirkelie, Co-founder and COO, at Genari AI. The company was
Rockwell Automation Fair 2025 Event Brief Axendia participated in The Rockwell Automation Fair 2025, held in Chicago, IL. This year, the event attracted over 15,000
Intelligent Autonomous Systems Fuel the Future of Industry Read More »
Insights from the 2025 Blue Mountain Summit The 2025 Blue Mountain Summit brought together industry leaders, experts, and innovators to discuss the latest trends, practices,
Blue Mountain Unveils Ambitious Product Roadmap Read More »
2025 Veeva R&D And Quality Summit Event Brief Axendia is grateful for the opportunity to once again cover the Veeva R&D and Quality Summit in Boston from
Industry Platform for Life Sciences Adds AI and Standard Applications Read More »
Are You Ready to Accept the Agency’s Challenge? FDA is taking a step to advance the integration of Generative Artificial Intelligence (GenAI) into healthcare by
FDA is Challenging You to Democratize and Demystify AI Read More »
